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Background: Visualized histopathological findings in tissue samples are not specific for
tuberculosis while mycobacterial cultures from such specimens have low yields and long
turn around times. A rapid, sensitive method is therefore needed for detection of Mycobac-
terium tuberculosis in paucibacillary tissue samples.
Methodology: In this paper, a total of 158 tissue specimens, including 42 culture-positives,
were tested for the presence of Mycobacterium tuberculosis by strand displacement amplifi-
cation of DNA targeting the region of the insertion element IS 6110 and detected by a
chemiluminescence based commercial platform (BDProbeTecTM ET System). The amplifica-
tion results were correlated to histopathology, microscopy and microbiological culture.
Results: The strand displacement amplification based assay showed low overall sensitivity
(31.5%) but high specificity (97.5%) which varied across various tissue types. Only 35.7% of
culture-positive biopsies were positive by the molecular assay. Some discrepancy were
attributed to suboptimal performance of the traditional methods.
Conclusions: The assay is useful to rule in the disease in common tissue specimens (lung,
pleura and lymph node); but less so in other tissue types. The poor sensitivity in tissue
specimens necessitates careful interpretation of data generated by the assay in conjunc-
tion with a clinical suspicion of tuberculosis for making decision regarding empirical treat-
ment. The complexity of the disease pathology along with the low bacillary load and
clumping tendency require selection of more sensitive methods or gene targets.
 2012 Asian-African Society for Mycobacteriology. All rights reserved.Introduction
Diagnosis of tuberculosis (TB) in tissues represents a diagnos-
tic challenge since the disease tends to be paucibacillary with
a subsequent low yield of acid-fast microscopy [1,2]. While
bacteriological confirmation is helpful and essential for speci-
ation and susceptibility testing, it is time-consuming owing to
the long generation time of the organism, as well as the tech-
nical difficulties in growing mycobacteria from tissue sam--African Society for Myco
Alnimr).ples. For these reasons, a rapid histopathological diagnosis
of TB is valuable to initiate treatment promptly and apply
appropriate infection control measures. In additions, rapid
diagnosis of TB has a considerable cost impact on healthcare
institutions [3].
Mycobacterium tuberculosis bacilli are visualized in tissue
sections using specialized stains, including the traditional
Ziehl-Neelsen stain. Diagnosis of TB from representative tis-
sue biopsy samples is supported by the presence of caseatingbacteriology. All rights reserved.
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glycolipid component of the mycobacterial cell wall is
thought to induce caseation [4]. While the presence of case-
ous necrosis is highly suggestive of TB, this finding can be
apparently confused with invasive mycoses, such as crypto-
coccosis and histoplasmosis. Necrotizing non-granulomatous
lesions can also be attributed to tissue TB [5], and thus can be
confusedwith other necrotizing pathological lesions. Further-
more, the histopathological features of TB may show consid-
erable variation and are largely dependent on the underlying
immune response [6]. The anergic histopathological presenta-
tion of TB is being increasingly recognized with the advent of
the era of immunosuppressed patients, making the distinc-
tion between TB and other chronic conditions particularly dif-
ficult on morphological grounds alone. This shows the critical
need for rapid, accurate tissue diagnostics, such as the nu-
cleic acid amplification tests for TB (NAATs-TB). The chief role
of those assays is a rapid mean for presumptive diagnosis of
TB, which justifies the initiation of therapy in cases where
clinical judgment alone does not favor doing so. Genetic tar-
gets that have been used for detecting M. tuberculosis include
IS 6110, 65KD heat shock protein, MPB 64, 38KD protein and
ribosomal RNA [7]. Various molecular approaches have been
successfully applied for detecting mycobacterial DNA by com-
mercial platforms with the principle based on either conven-
tional PCR techniques followed by sequencing of the
amplified product, solid phase hybridization, or real-time
amplification methods like the strand displacement amplifi-
cation (SDA). The advantages of such systems are better qual-
ity control of reagents, user-friendly format and potential of
automation [8]. However, these commercial systems have
been inadequately validated in non-respiratory specimens,
and the accuracy of NAATs-TB in this context remains un-
clear with previous reporting of inadequate diagnostic accu-
racy and, in particular, false positives in various clinical
settings [9]. Of significance is the poor sensitivity in detecting
mycobacterial DNA in clinical specimens compared with cul-
tures [10].
The SDA, an isothermal amplification assay, is based on
the ability of the Klenow fragment of Escherichia coli DNA poly-
merase to start at the site of a single stranded nick in double
stranded DNA. This is followed by extending one strand from
the 3 end and displacement of the downstream strand of the
DNA [11]. The replicated DNA and the displaced strands are
then substrates for further annealing, nicking and strand dis-
placement. This results in geometric amplification (108 folds
amplification reaction in 2 h). Thus, the SDA process has a
low detection limit of around 10–50 copies, so when the target
is present in several copies in the genome of the organism
(e.g. IS 6110 in M. tuberculosis), only a few number of the bac-
terium is required for detection [12]. The BDProbeTec system
(Becton Dickinson), adopted in this study, provides a myco-
bacterial-specific platform for SDA coupledwith a chemilumi-
nescence detection system. This allows the whole sensitive
assay to be performed in 4 h following the processing and
decontamination of specimens if required, so the assay is a
convenient alternative for real-time PCR [13]. Since its initial
description and evolvement, the ProbeTec has been evaluated
mainly in respiratory specimens, but also in non-respiratory
fluid samples [14,15]. Limited data, however, exist regardingits performance in tissue biopsies. A study was conducted
to evaluate the diagnostic performance of the BDProbeTec
system in various tissue samples and its concordance with
histopathological examination (HPE) and bacteriological
culture.Materials and methods
Study settings and specimens
This comparative study was conducted between and includ-
ing January 2011 and April 2012 in the Diagnostic Laboratories
of a tertiary care center in Saudi Arabia. One hundred and
fifty-eight tissue samples were processed for both SDA and
HPE. Tissue samples for SDA were sent in normal saline and
for histopathology in 10% formalin. All the samples were kept
at 4 C before processing.
Bacteriological methods
All the tissue biopsies were dissected, manually macerated
and homogenized using a sterile tissue grinder then subjected
to decontamination by a standard N-acetyl-L-cysteine (NALC)
digestion method. Briefly, specimens were treated with an
equal volume of NALC–NaOH (final concentration 2%) for
15 min at room temperature, neutralized with sterile phos-
phate buffer (pH 6.8), and centrifuged at 3000g for 30 min.
The sediment pellet was then re-suspended in 2 ml phosphate
buffer and subjected to both culture and SDA analysis using
the BDProbeTec ET system following manufacturer’s instruc-
tions. Culture was performed using two Lo¨wenstein-Jensen
slopes (with and without pyruvate), and the MGIT (Becton
Dickinson) liquid culture system according to the manufac-
turer’s instructions. All specimens were screened microscopi-
cally after concentration using the Auramine stain with
positive results confirmed using Ziehl-Neelsen staining.Molecular methods
Following the manufacturer’s instructions, 500 ll post-decon-
tamination specimens were washed with 1 ml wash buffer 1,
and then centrifuged at 12,200g for 3 min. The supernatant
was discarded and mycobacteria were subjected to killing by
heat (105 C) for 30 min. DNA was released from the organ-
isms by re-suspending the deposit in 100 ll lysis buffer 2, fol-
lowed by sonication at 65 C for 45 min. Samples were then
neutralized by adding 600 ll neutralization buffer. A volume
equivalent to 150 ll DNA extract was added to the priming
well containing dehydrated primers and probes in the micro-
titer plate. The plate was incubated at room temperature for
20 min to allow complete rehydration of reagents. The prim-
ing mix was incubated at 72.5 C for 10 min. Enzymes, dNTPs
and buffer were activated in a separate amplification microti-
ter plate by heating to 54 C for 10 min. Hundred microliter of
the priming mix was added to each corresponding well and
mixed to initiate amplification. Plates were then transferred
to the BDProbeTec analyzer. Each assay run was done in
duplicate and included positive and negative controls, along
with the assay supplied internal control to avoid false-nega-
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specimens. Samples that gave a MOTA (method other than
acceleration) fluorescence score of P3400 were regarded as
positive, and those with a MOTA score of 63400 were consid-
ered negative for mycobacterial DNA.
Histopathological examination
Tissue specimens received for HPE were fixed in 10% formalin,
embedded in paraffin, cut to 3-lm thick sections, and stained
with hematoxylin–eosin (H&E) before microscopic examina-
tion. Presence of any or a combination of the following crite-
ria – well-defined granulomatous inflammation, caseous
necrosis, typical caseating granulomas or Langhans giant
cells – indicated possible tubercular involvement of the tissue
regardless of the Ziehl-Neelsen staining status and the result
was compared with the parallel bacteriological culture and
nucleic acid amplification assay. Poorly defined or non-spe-
cific inflammatory findings were categorized as histopatho-
logically negative for typical tubercular lesions.
Discrepant findings
If there was any discrepancy among culture, BDProbeTec SDA
or HPE results, a second aliquot of the frozen specimen that
had been processed for amplification was retested by the
BDProbeTec. When discrepancy among the laboratory assays
persisted, cases were traced for the possibility of TB as a final
diagnosis.
Data analysis
Analysis was performed using Graphpad Prism 5.0 on a spec-
imen-basis, not on a patient-basis, to allow assessment of the
parallel laboratory assays.
Results
Out of 42 culture-positive cases, only 15 (35.7%) were detected
by nucleic acid amplification using the SDA-based BDProbe-
Tec ET system (Table 1). Histopathology was positive in 44
cases; of which 3 were culture-negative. The two cases where
TB was a final diagnosis (lymph node in a known TB patient
and peritoneal tissue specimen from a dialysis patient who
improved dramatically on empirical anti-TB treatment), SDA
was helpful as an early marker of TB in these cases as well
as in one lung tissue specimen where histopathology wasTable 1 – Results of strand displacement amplification (SDA), cult
the 158 tissue specimens.
SDA HPE positive (44)
Culture-positive (41) Culture-negative (3)
Microscopy
positive
Microscopy
negative
Microscopy
positive
Mic
neg
Positive (15) 1 (intestine) 11 2 (Peritoneum
and lymph node)
0
Negative (143) 0 29 0 1 (Jnon-specific which was smear-negative, but SDA-positive
and later culture-positive. An alternative final diagnosis was
considered in one case of granulomatous joint reaction where
neither culture nor SDA was positive. Table 2 illustrates the
performance of the different laboratory assays in various
types of tissue specimens included in the study. Only one case
of tissue TB (intestinal biopsy) showed positive reactions in all
bacteriological, molecular and histopathological examina-
tion. The sensitivity of SDA ranged between 0% and 50% com-
pared with culture, and between 12.5% and 50% in relation to
histopathology. Overall specificity ranged between 96.6% and
92.8%. The PPV for SDA was variable among various tissue
types (pleura, lymph node and intestinal tissue). Sensitivity,
specificity, and positive and negative predictive values of the
SDA are shown in Table 3, assuming that either histopathol-
ogy or bacteriological cultures are the standard reference as-
says in either column.
Discussion
Nucleic acid amplification tests (NAATs) have the potential to
shorten clinical detection of M. tuberculosis from weeks to a
few hours. The semi-automated real-time BDProbeTec SDA
system allows simultaneous amplification and detection of
the M. tuberculosis DNA-specific target IS 6110 using the
amplification primers and fluorescently labeled probe [14].
The isothermal nature of SDA eliminates the need for cyclers
and makes it ideally suited to in situ-based applications in
which the morphology of the tissue sections is preserved
[16]. Additional practical advantages of the system include:
the presence of internal amplification control (thus spiking
is not required), the semi-quantitative nature of the assay,
multiplexing and batching potential for testing a large num-
ber of samples, and the autoclave-based lysis of samples.
These features favor the adoption of the simplified protocol
in routine TB laboratory settings [13]. However, data regarding
its performance in tissue specimens are limited.
The relatively low temperature at which the SDA-based as-
says is carried out (52.5 C) is expected to result in non-
stringent amplification and the occurrence of non-specific
binding, especially when the target is absent or present in
low copies compared with the background DNA. This draw-
back is reflected as poor specificity with a negative diagnostic
performance of the testing platform. In this study, however,
when the BDProbeTec was utilized to supplement histopa-
thology in detecting TB in characteristic tissue lesions, the
high positive predictive value (PPV) in common specimensure, microscopy and histopathological examination (HPE) for
HPE negative (114)
Culture-positive (1) Culture-negative (113)
roscopy
ative
Microscopy
positive
Microscopy
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Microscopy
positive
Microscopy
negative
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kely to be a false one. This was applicable to tissue specimens
originating from pleura, lymph node, intestine and lung.
Although the table shows a PPV of 66.78% in lung tissue, this
was interpreted by the presence of a case of non-specific
chronic inflammatory findings in the lung where TB was the
final diagnosis based on culture. Thus, the PPV and specificity
were restored when the performance of NAATwas compared
with the culture (Table 3). For other less common types of tis-
sues including orthopedic specimens, specificity was moder-
ate and the assay performance was less accurate in ruling
out or ruling in the diseases. This may reflect differences in
tissue matrix digestibility and efficiency of DNA extraction
from such tissues, e.g. calcified bone or the inhibitory activity
owing to some tissue components [17]. Since there is no gold
standard laboratory test for extra-pulmonary TB, this margin-
ally low specificity may represent lack of concordance with
the reference methods rather than poor performance of the
assay. This is thought to be the case since the clinical data
supported the diagnosis of TB in 2 samples that were positive
by SDA but not culture which has low yield in tissues. The
peritoneal tissue sample with a positive NAAT-TB but nega-
tive culture and HPE (Table 2) was clinically diagnosed as TB
and responded to anti-tuberculosis treatment. However, it is
difficult to infer the performance of the assay in this type of
specimen owing to the limited number of specimens tested.
The other case with a positive HPE but negative culture was
a lymph node obtained from a patient who was diagnosed
as a case of TB by culture from a non-tissue specimen who
failed treatment and presented with disseminated TB. For
such cases, the NAAT is useful as a clue to TB, with and with-
out suggestive histopathological findings, awaiting culture re-
sults although the clinical decision needs to consider the lack
of technical experience and data about the system perfor-
mance in tissues [18]. The inaccuracy of the reference meth-
ods negatively impacted the apparent specificity and PPV of
the assay in comparison with the culture (Table 2). The overall
good specificity findings can be attributed to the technical
improvements on the assay to optimize specificity, including
the thermophilic adjustment, and the use of the recently
available thermostable polymerases and organic solvents. In
addition, the specificity is largely influenced by the target
genes and primer design.
Sensitivity of the SDA assay was a main concern in this
study. Overall sensitivity was poor (Table 3) as SDA was able
to detect only one third of the TB cases as suggested by HPE
and/or bacteriological cultures. The MOTA scorewas reviewed
for false negative cases by SDA and found some scores were
close to the cut-off value, but could not identify an alternative
threshold to raise the sensitivity without compromising the
specificity in tissue samples (data not shown). The reported
sensitivity is inadequate to recommend using the assay for
routine confirming or ruling out TB in suspected tissue spec-
imens with granulomas in diagnostic settings. A report of
SDA-BDProbeTec was published with higher sensitivity than
observed in this study, although the assay was performed
on formalin-fixed, paraffin-embedded tissues [19]. The find-
ings, however, were fit into the published data about other
non-SDA NAATs for detection of TB in tissues [20–22] in which
the sensitivity of NAATs for detection of TB in the tissues was
Table 3 – Sensitivity, specificity and predictive values of the BDProbeTec ET system in comparison with the standard
laboratory assays for various specimen type (a) histopathological examination is used as a reference, (b) culture is the
reference.
Type of tissue
(number of samples)
HPE Culture
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Lung (51) 12.5 97.7 66.78 75.12 22 100 99.99 77.61
Pleura (45) 33.3 100 99.99 80.21 33.3 100 99.99 80.21
Lymph nodes (38) 39 100 99.99 81.59 38 93.8 69.39 80.36
Intestine (11) 50 (only 2) 100 99.99 84.39 50 (only 2) 100 99.99 84.39
Others (13) 20 87.5 25.60 72.63 0 77.8 0 67.78
Total (158) 32 98.2 87.25 78.95 30.9 96.6 77.07 79.08
174 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 1 ( 2 0 1 2 ) 1 7 0 –1 7 6found to be variable between as low as 24% to very high
(>90%). The poor sensitivity of a molecular NAAT could be re-
lated to the limit of detection of the assay and the strain
genotype. It should be noted that biopsy specimens are usu-
ally obtained from sites with macroscopic pathology. Such
sites are expected to have a vigorous immunological reaction
and very few live bacilli [23]. Also, the abundance of copies of
the target gene sequence is an important determinant of
NAAT sensitivity. The commercial molecular assays are based
upon kits innovated in the developed world so they represent
certain lineages of strains. There have been reports about
Mycobacterial isolates from some geographical areas like
the Indian subcontinent lacking or having only a few copies
of IS 6110 [24], compared with (8–15) copies usually found in
strains from theWestern Countries where most molecular as-
says are developed. A recent study by Al-Hajoj et al. found
that the Asian mycobacterial lineages represent a significant
proportion of the circulating strains in Saudi Arabia [25]. How-
ever, the amplification scores of most false-negative speci-
mens were close to the cut-off value, suggesting that it is an
assay limitation rather than a strain-related finding. In addi-
tion, the diagnostic performance of molecular assays for M.
tuberculosis relies much on the bacterial load in tissues, qual-
ity of the representative specimen, laboratory infrastructure
and efficiency of DNA extraction. Increasing the sample input
volume improves the performance of molecular assays [26],
and a brief incubation of biopsy tissues on Lo¨wenstein-Jensen
slopes was found to improve mycobacterial DNA extraction
from tissues and to raise the sensitivity of NAAT by around
50% without compromising the specificity [17]. For all types
of tissues, the negative predictive value (NPV) was found to
be less than 90%, so the BDProbeTec system was not suitable
to rule out TB in tissues with granulomas. This is of great clin-
ical significance as NAATs will be clinically useful when they
reliably rule out TB in tissues with negative acid-fast staining.
This was not the case in the presented data raising the ques-
tions about the reliability and cost-effectiveness of their rou-
tine use in tissue specimens.
The BDProbeTec system is marketed as a qualitative sys-
tem as the original paper describing the method showed that
the numerical data produced (MOTA) was not a quantitative
measurement that can be used to infer the level of target
DNA [27]. The scores are thus considered purely qualitative
since they are influenced by several parameters other than
the amount of the target in the clinical specimens like the
sample matrix, kinetics associated with the molecular inter-actions and slight variations in the reagent, hardware, envi-
ronment or workflow. McHugh et al. noted that diagnostic
inaccuracies were encountered in the low-positive zone with
lower scores [14]. It was found that while the sensitivity was
poor in lung tissues, the amplification score was excessively
high in both positive lung tissues (>100,000 MOTA) compared
with those found in other tissues. This suggests a relatively
higher bacillaryl load which could be incidental, since only
two cases of lung tissueswere positive by the BDProbeTec sys-
tem, or it could be owing to the different pathological events
in pulmonary TB. The microscopy yield was unsurprisingly
low (7%) in the study. Alternative staining techniques have
been proposed to improve microscopic yield in tissues, such
as Triff stain which demonstrates both the organisms and
the background tissue pathology allowing better correlation
with the pathological process [28], the Silver impregnation
Dieterle or Warthin Starry methods [29], and the fluorescence
Auramine–Rhodamine dye, which is only suitable for cytolog-
ical examination [30]. The immunohistochemical detection
method has also been developed, but is not widely used [31].
A drawback of this study design is that molecular analysis
was performed on specimens sent to the TB laboratory, and it
does not include tissues sent to pathology without a corre-
sponding specimen in the TB laboratory. This might have con-
tributed to the high specificity results found. When all
histopathological tissues are included, it is expected that
there will be some TB cases as suggested by histopathology
findings. Although this study contained a small subset of TB
cases with only a small number of certain tissue types (intes-
tine, peritoneum, orthopedic specimens), it showed an inade-
quate diagnostic performance of a commercially available
NAAT system on tissue specimens and the need for a more
reliable testing system for testing non-respiratory specimens.
Such a system needs to be user friendly and internally-quality
controlled. Global efforts are currently focused on developing
diagnostic systems useful for certain parts of the world with
high disease burden and low economy. While investing in
these diagnostics is valuable to meet the Millennium TB Tar-
gets, simple commercial diagnostic platforms with optimal
diagnostic performance are required for countries with a good
economy, modest burden of the disease, high proportion of
extra-pulmonary TB cases, and low expertise in the labora-
tory settings. The in-house developed and quality-controlled
amplification assays are unsuitable options for such countries
with a rapid turnover of staff and low technical experience.
The evaluation of the newly launched GeneXpert and the
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effectiveness of those assays for routine use in tissue samples
with possible TB involvement. This will not only aid in rapid
identification of TB, but will also screen for drug-resistant TB.Conclusions
In summary, the data suggest that the BDProbeTec Test is a
specific technique used for detection of M. tuberculosis
complex directly in common tissue biopsies. The number of
positive cases of TB in this study is small; therefore, further
studies are required to confirm the findings. The sensitivity
of the assay is inadequate, so it is not recommended for rou-
tine diagnostic use in such extra-pulmonary samples. The
major problem with the assay in this evaluation was false-
negative results, which could be related to inherent or techni-
cal grounds. While NAATs are expected to revolutionize the
diagnosis of mycobacterial diseases owing to their speed,
accuracy and sensitivity, their application for a reliable diag-
nosis of extra-pulmonary TB is lagging behind. The search
for a commercially available, quality-controlled system for
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